+ T regs in immune tolerance, with transforming growth factor-beta (TGF-β) serving as a potential link between these two professionals.
DCs
DCs are a sparsely distributed, migratory population of bone-marrow-derived leukocytes that are specialized in the recognition, uptake, transport, processing and presentation of antigens to T cells (1-3). Firstly discovered as the most important APCs in initiating innate and adaptive immunity to infections and other non-self antigens, DCs have been recently recognized as also a crucial player (determinant) in induction of T cell tolerance. To reconcile the two paradoxical functions of DCs, a number of mechanisms have been introduced. In this regard, it has been demonstrated that DCs, at an "immature" stage of development in the 'steady state' (absence of inflammation), act as sentinels in peripheral tissues, continuously sampling antigenic environment and inducing tolerance by the deletion of naïve peripheral T cells and the induction of regulatory T cells (2, 3). When encountered with infection, inflammation and other "danger" signals, "immature" DCs migrate to the draining lymph nodes and become "mature" DCs marked by upregulation of several surface molecules such as CD11c, CD80, CD86, MHC class I and II, CD40 and by acquisition of a unique marker CD83 to initiate T cell immune responses (2, 3).
Immature DCs can reside in the non-lymphoid and lymphoid tissues. DCs in the thymus, Langerhans cells in skin, mucosal DCs in Peyer's patch (PP) in intestine (4) and in lungs and DCs in spleen are examples of immature DCs. Thymic DCs reside almost exclusively in the medulla. One of the most prominent functions of thymic DCs is to delete self-reactive specific T cells (3). In periphery, immature DCs may function as immunoregulatory cells. Immature DCs are able to delete self-antigen or harmlessantigen specific T cells when targeted with the respective antigens under the steady state. In addition, immature DCs possess the ability to capture and digest apoptotic cells and present the antigen of the apoptotic cells to specific T cells, which may result in T cell tolerance. It is however unclear whether immature DCs may also produce immunosuppressive cytokines TGF-β and IL-10 upon the phagocytosis of apoptotic cells as macrophages do (5, 6). Finally, immature DCs may induce IL-10 producing T regulatory (Tr1) cells (7) and CD4 + CD25
+ T regs (8), which may actively suppress immune responses.
When encountered with microbial antigens and inflammation, immature DCs will change their phenotype and function to become "mature DCs". During maturation, DCs dampen their endocytic receptor expression and lose their endocytosis capacity(2). Many inflammatory and noninflammatory antigens induce immature DCs to mature. A number of microbial products may activate DCs through the Toll-like receptors (TLRs) (2). Some proinflammatory stimuli can also drive DCs to mature through pathways distinct from TLRs. These include several TNF family members like TNFα itself, FasL, and CD40L, Fc receptors for immune complexes, IFN-α produced by plasmacytoid DCs (9), certain types of necrotic cells and certain innate cell types such as NK cells, γδT cells, and NKT cells (2). The original hallmark of DC function involves the induction of T cell proliferation and stimulation of T celldependent antibody production (2 
CD25
+ T regs remain to be elucidated (33) . Recent evidence has started to reveal that 
+ T regs, which may influence immune responses (34, 35) . It is however unclear how CD4 +
+ T regs associated with HIV infection are generated and regulated and it is premature to state whether CD4 +
+ T regs play a "good" or "bad" or even "ugly" role in HIV infection. Although CD4 +
+ T regs have been unanimously recognized as one of the major players in maintaining normal immune tolerance and in influencing pathogenesis of various diseases, two mysteries of T regs however still remain largely unresolved, i.e. mechanism(s) of suppression and pathway(s) of development. 
+ T regs carefully, it would not be difficult to summarize that the ideal molecule must meet at least the following preconditions. For easy reading, I mark this potential molecule as M (Figure 1 ). 1) M has to be on the surface of T regs; 2) After TCR stimulation, M should be enhanced, induced, prevented from degradation or activated to its bioactive form on the cell surface of T regs; 3) When high levels (>100 u/ml) of IL-2 (plus TCR stimulation) are present in cultures, M should be expressed or even increased on T regs. Importantly, once IL-2 is removed, M should still exist on T regs; 4) The target cells (e.g. CD4 Based on aforementioned pre-conditions, most of the molecules on the list except TGF-β are unlikely the one that directly mediates the immunosuppression by CD4 +
+ T regs, because they may meet some of the requirements, but fail to fulfill all preconditions. Although T regs express CD25, there is no evidence that CD25 on T regs could bind surface IL-2 (if any) on target cells to deliver an inhibitory signal. IL-2 is required for the homeostasis and survival of CD4 +
+ T regs, but it is unlikely that IL-2 binds CD25 or its other receptors on responder T cells to deliver an inhibitory signal to suppress T cell proliferation. The opposite effect is true. Although Granzyme B mediated cell death might be responsible for some suppressive effects induced by T regs to their target cells (36, 37) , it is unlikely the major factor, because ample evidence has clearly shown that most of the suppressed cells still remain alive in vitro and in vivo (19, 38) . Although LAG-3 is expressed predominantly on CD4 +
+ T regs (39) , there is no evidence that LAG-3 on T regs and its receptor (ligand?) on responder cells could deliver a suppressive signal. Foxp3 is the most specific marker and the master gene for the development of CD4 + CD25
+ T regs, but the role of Foxp3 as a mediator for the suppression of T regs seems unlikely. Foxp3 is a transcription factor in the nucleus (12) and can not be expressed on the surface of T regs. The best scenario (if any) would be that Foxp3 interacts with other suppressive molecules that in turn mediate the suppression by T regs.
+ T regs may produce higher levels of IL-10, the cell-contact requirement precludes the soluble factor as a main mechanism, and indeed, anti-IL-10 or IL-10 receptor antibodies fail to block immunosuppression in vitro. There is no evidence that CD4 + T regs was however originally disregarded based on the fact that T regs needed cell-contact, but TGF-β was normally regarded as a soluble cytokine. The discovery that CD4 + CD25
+ T regs express cell membranebound latent TGF-β (LAP-TGF-β), active TGF-β has reinvigorated investigation in this field (45, 48, 49) . When TGF-β is placed into the aforementioned pre-conditions, it is intriguing to note that TGF-β fulfills all the requirements. First, TGF-β is expressed on the cell surface of CD4 + CD25 + T regs. In addition, T regs also express higher levels of TGF-β receptor II (TβRII), a binding receptor for TGF-β, which may explain the anergy of T regs to TCR stimulation, because the binding between autocrine or paracrine membranebound TGF-β and TβRII on T regs may inhibit TCR induced proliferation (45) . Second, when CD4 + CD25 + T regs are activated via TCR stimulation and in the presence of IL-2, the expression of cell membranebound TGF-β on T regs persists and even increases (45, (48) (49) (50) . Importantly, once exogenous IL-2 is removed, T regs still express high levels of cell membrane-bound TGF-β (45, 49, 50) . Third, naïve CD4 + CD25 -T cells express very low levels (if any) of TβRII, but it increases significantly after TCR stimulation (45) . In a co-culture system, cell membrane-bound TGF-β on T regs could bind TβRII on CD4 +
-responder T cells to deliver a negative signal, which can be demonstrated by upregulation of P-Smad2/3 in responder T cells (45, 50) . Fourth, TGF-β suppresses its target cells in an antigen non-specific manner and even among species (51). Finally, high levels of exogenous IL-2 are able to abrogate TGF-β mediated immunosuppression of T cell activation (45, 52, 53 Although TGF-β fits well aforementioned preconditions and growing evidence has gradually appreciated it as a critical mediator in suppression induced by CD4 + CD25
+ T regs, two pieces of unresolved puzzles still prevent TGF-β from getting universal recognition. First, it remains to be elucidated why some of anti-TGF-β antibodies cannot reverse suppression by T regs in co-cultures. Besides the different systems used in individual laboratory, it is likely that the unique structure and/or conformation of cell membrane-bound TGF-β might prevent the binding of anti-TGF-β antibodies to inactivate its activity, whereas the same antibody could effectively neutralize the activity of soluble TGF-β. The other mystery is why CD4 + CD25
+ T cells in TGF-β1-/-mice still possess suppressive function in cultures.
Several possibilities need to be considered to resolve this issue. First, TGF-β1 is the dominant (in normal situation), but not the only isoform of TGF-β in regulating immune responses. In the absence of TGF-β1, TGF-β2 and/or 3 may compensate for the TGF-β signal transduction, because all TGF-β1, 2 and 3 bind the same receptors and execute the same signals in vitro, although they may not substitute each other in vivo. Additionally, the ability of CD4 + CD25
+ TGF-β1-/-T cells to effect suppression in cultures must be viewed with caution since maternal transfer of TGF-β and its passive binding to these cells cannot be excluded. It is unclear at present that the cell membrane-bound TGF-β on normal CD4
+ T regs is solely produced by the T reg or it can be also passively bound onto T regs (45) . Finally, it should be noted that in addition to T regs, many other cells including macrophages/monocytes, DCs, epithelial cells, myeloid suppressor cells and tumor cells also produce a large amounts of TGF-β. The TGF-β produced from non-T reg cells may explain the unexpected TGF-β-dependent immunosuppression by TGF-β1-/-CD4 + CD25
+ T cells in vivo (54). 
Generation of CD4 + CD25 + T reg

ROLE OF DCS IN THE INDUCTION/EXPANSION OF CD4 + CD25 + T REGS
One of the proposed mechanisms is that inhibitory DCs induce immune tolerance by inducuction and/or expansion of T regs. It has been shown that DCs may induce Tr1 through IL-10 (7, 59, 60) (Figure 2 ). If a naïve T cell encounters its antigen on immature DCs, it may differentiate into Tr1 rather than a T-effector cell (61). This can be obtained by repetitive exposure of naïve peripheral blood CD4 + T cells to allogeneic immature DCs. In another report, in vitro culture of bone marrow cells in the presence of IL-10 induced differentiation of a distinct subset of DCs with a specific expression of CD45RB (60). These CD11c low CD45RB high DCs display plasmacytoid morphology and an immature-like phenotype and secrete high levels of IL-10 after activation. OVA peptide-pulsed CD11c low CD45RB high DCs specifically induce tolerance through the differentiation of Tr1 cells in vitro and in vivo. Interestingly, antigen-exposed DCs in which RelB function is inhibited lack cell surface CD40, prevent priming of immunity, and suppress previously primed immune responses (62). These RelB -
CD40
-DCs induce Tr1 cells and transfer antigen-specific "infectious" tolerance to primed recipients in an IL-10-dependent fashion. Thus, immature DCs can drive the differentiation of Tr1 cells. Since CD4 +
CD25
+ Tr1 cells produce IL-10, it would be conceivable that T regs contribute to this process, at least in vivo, but the definite correlation remains to be established. 
DC REGULATION OF SUPPRESSIVE ACTIVITY OF CD4 + CD25 + T REGS
In addition to overcoming anergy of T regs, mature DCs may reverse the immunosuppression induced by CD4 + T regs, restoring responder T cell proliferation to near normal levels (74, 76). The DC-mediated inhibition of suppressor activity was independent of co-stimulation (74, 76), but was dependent in part on interleukin-6 (IL-6), which was induced by TLRs upon recognition of microbial products. These findings have provided an explanation for DCs (particularly mature DCs) to initiate immune responses rather than tolerance to foreign antigens. Several interesting questions however remain to be answered. 
TGF-β: A MEDIATOR OF CROSSTALK BETWEEN DCS AND CD4 + CD25 + TREGS?
Since TGF-β is one of the most critical immunoregulatory cytokines in regulation of immune responses (51, 86), a role of TGF-β in mediating the crosstalk between DCs and CD4 + CD25
+ T regs is inevitably considered. As discussed, CD4 + CD25
+ T regs express cell membrane-bound as well as soluble TGF-β (45, 50) that can be responsible for the suppressive activity of T regs. It would be reasonable to envision that CD4 +
CD25
+ T regs regulate DC function at least in part through TGF-β. TGF-β has been shown to stimulate epithelial Langerhans cell (LC) differentiation from hematopoietic progenitor cells or from a monocytic differentiation pathway (73). It is of interest to note that the effect of TGF-β is a dose dependent in serum-free culture medium. Low concentration of TGF-β (0.5 ng/ml) promotes proliferation and differentiation of CD34 + progenitor to LC-like DCs, but higher concentrations suppresses LC differentiation and proliferation in the same cultures (73). This phenomena is consistent with the differential role of TGF-β in regulation of T cell proliferation (51-53). Importantly, DCs generated from human hematopoietic progenitor cells in the presence of TGF-β lack mature DC features. For example, TGF-β induced DCs fail to express CD83 (CD83 -) and have low levels of CD86 (CD86 dim ) (73). Similar evidence was obtained in TGF-β1 mediated differentiation of DCs in cultures of murine bone marrow cells, resulting in DCs expressing MHCII low and CD86 dim . Effect of TGF-β on differentiation of LC cells was also confirmed in vivo. TGF-β1-/-mice selectively lack epidermal LC (87) . In contrast to a potential enhancement of differentiation of immature DCs, TGF-β may suppress maturation and function of mature DCs (73). Interestingly, it has been recently shown that splenic stromal cell-derived TGF-β induces mature DCs to differentiate into a type of regulatory DC (88) . This type of regulatory DCs strongly inhibited proliferative responses of naïve CD4 + T cells to antigen stimulation by mature DCs.
On the other hand, DCs also produce TGF-β. Immunohistology studies have revealed expression of TGF-β protein in LCs (89) . In vitro-generated DCs also abundantly synthesize TGF-β1 (73). TGF-β1 mRNA can be detected in LC-type and germinal center-type DCs generated in cultures of CD34 + cord blood. Although TGF-β produced by DCs may play a role in the development of CD4 +
+ T regs, a direct connection is still missing. An unresolved but fascinating question is that under which conditions DCs produce TGF-β. Since both immature and mature DCs can produce TGF-β, it would be more informative to analyze TGF-β quantitatively rather than qualitatively and compare it with other inflammatory cytokines and factors to determine the role of DC in inhibition or promotion of T cell responses.
SUMMARY
CD4 +
CD25
+ T regs and DCs represent the two most important populations of cells in regulation of immunity and tolerance. It takes these two types of professionals to complete the task. The question is how they interact. By reinforcing our investigations on underlying molecular events and mechanisms of interaction between CD4 + CD25
+ T regs and DCs, and extending our studies to autoimmune diseases, chronic inflammation, transplantation, cancers, bacterial and HIV infections, it may become possible to manipulate host offense and defense.
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